Your browser doesn't support javascript.
loading
Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma.
Liu, Kuancan; Xie, Fuan; Zhao, Tingting; Zhang, Rui; Gao, Anding; Chen, Yunyun; Li, Haiyan; Zhang, Shihui; Xiao, Zhangwu; Li, Jieping; Hong, Xiaoqian; Shang, Lei; Huang, Weifeng; Wang, Junkai; El-Rifai, Wael; Zaika, Alexander; Chen, Xi; Que, Jianwen; Lan, Xiaopeng.
Afiliación
  • Liu K; School of Medicine, Xiamen University or Institute for Laboratory Medicine, 900 Hospital of the Joint Logistics Team, Fuzhou, Fujian 350025, China; Dongfang Hospital, Xiamen University, Fuzhou, Fujian 350025, China; Fuzhou General Hospital Clinical Medical School, Fujian Medical University, Fuzhou 3
  • Xie F; School of Medicine, Xiamen University or Institute for Laboratory Medicine, 900 Hospital of the Joint Logistics Team, Fuzhou, Fujian 350025, China.
  • Zhao T; School of Medicine, Xiamen University or Institute for Laboratory Medicine, 900 Hospital of the Joint Logistics Team, Fuzhou, Fujian 350025, China; Dongfang Hospital, Xiamen University, Fuzhou, Fujian 350025, China.
  • Zhang R; School of Medicine, Xiamen University or Institute for Laboratory Medicine, 900 Hospital of the Joint Logistics Team, Fuzhou, Fujian 350025, China.
  • Gao A; School of Medicine, Xiamen University or Institute for Laboratory Medicine, 900 Hospital of the Joint Logistics Team, Fuzhou, Fujian 350025, China.
  • Chen Y; School of Medicine, Xiamen University or Institute for Laboratory Medicine, 900 Hospital of the Joint Logistics Team, Fuzhou, Fujian 350025, China; Dongfang Hospital, Xiamen University, Fuzhou, Fujian 350025, China.
  • Li H; Department of Pathology, Westechester Medical Center, Valhalla, NY 10595, USA.
  • Zhang S; School of Life Sciences, Central South University, Changsha, Hunan 410083, China.
  • Xiao Z; Emergency Department, 900 Hospital of the Joint Logistics Team, Fuzhou, Fujian 350002, China.
  • Li J; Department of Clinic Medical Laboratory, General Hospital of Fujian Corps of CAPF, Fuzhou, Fujian 350003, China.
  • Hong X; School of Medicine, Xiamen University or Institute for Laboratory Medicine, 900 Hospital of the Joint Logistics Team, Fuzhou, Fujian 350025, China; Dongfang Hospital, Xiamen University, Fuzhou, Fujian 350025, China.
  • Shang L; School of Medicine, Xiamen University or Institute for Laboratory Medicine, 900 Hospital of the Joint Logistics Team, Fuzhou, Fujian 350025, China; Dongfang Hospital, Xiamen University, Fuzhou, Fujian 350025, China.
  • Huang W; Medical College, China Three Gorges University, Yichang, Hubei 443002, China.
  • Wang J; School of Life Science, Xiamen University, Xiamen, Fujian 361102, China.
  • El-Rifai W; Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Zaika A; Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Chen X; Department of Medical Oncology, 900 Hospital of the Joint Logistics Team or Dongfang Hospital, Fuzhou, Fujian 350025, China.
  • Que J; Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA. Electronic address: jq2240@cumc.columbia.edu.
  • Lan X; School of Medicine, Xiamen University or Institute for Laboratory Medicine, 900 Hospital of the Joint Logistics Team, Fuzhou, Fujian 350025, China.
Mol Ther ; 28(3): 901-913, 2020 03 04.
Article en En | MEDLINE | ID: mdl-31991109

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aptámeros de Péptidos / Factores de Transcripción SOXB1 / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aptámeros de Péptidos / Factores de Transcripción SOXB1 / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2020 Tipo del documento: Article